Literature DB >> 10197834

Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.

K O Lim1, M Hedehus, M Moseley, A de Crespigny, E V Sullivan, A Pfefferbaum.   

Abstract

BACKGROUND: Current investigations suggest that brain white matter may be qualitatively altered in schizophrenia even in the face of normal white matter volume. Diffusion tensor imaging provides a new approach for quantifying the directional coherence and possibly connectivity of white matter fibers in vivo.
METHODS: Ten men who were veterans of the US Armed Forces and met the DSM-IV criteria for schizophrenia and 10 healthy, age-matched control men were scanned using magnetic resonance diffusion tensor imaging and magnetic resonance structural imaging.
RESULTS: Relative to controls, the patients with schizophrenia exhibited lower anisotropy in white matter, despite absence of a white matter volume deficit. In contrast to the white matter pattern, gray matter anisotropy did not distinguish the groups, even though the patients with schizophrenia had a significant gray matter volume deficit. The abnormal white matter anisotropy in patients with schizophrenia was present in both hemispheres and was widespread, extending from the frontal to occipital brain regions.
CONCLUSIONS: Despite the small sample size, diffusion tensor imaging was powerful enough to yield significant group differences, indicating widespread alteration in brain white matter integrity but not necessarily white matter volume in schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10197834     DOI: 10.1001/archpsyc.56.4.367

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  131 in total

Review 1.  New insights on the neuroanatomy of schizophrenia.

Authors:  G D Pearlson
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Stephan E Maier; Melissa Frumin; Paul G Nestor; Dean F Salisbury; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

3.  Isotropic resolution diffusion tensor imaging with whole brain acquisition in a clinically acceptable time.

Authors:  Derek Kenton Jones; Steve Charles Rees Williams; David Gasston; Mark Andrew Horsfield; Andrew Simmons; Robert Howard
Journal:  Hum Brain Mapp       Date:  2002-04       Impact factor: 5.038

Review 4.  Diffusion tensor imaging and its application to neuropsychiatric disorders.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Stephan E Maier; Hatsuho Mamata; Melissa Frumin; Hal Ersner-Hershfield; Ron Kikinis; Ferenc A Jolesz; Robert McCarley; Martha E Shenton
Journal:  Harv Rev Psychiatry       Date:  2002 Nov-Dec       Impact factor: 3.732

5.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

6.  Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.

Authors:  Patrick R Hof; Vahram Haroutunian; Christina Copland; Kenneth L Davis; Joseph D Buxbaum
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

7.  Functional neuroimaging in mental disorders.

Authors:  Philip K McGuire; Kazunori Matsumoto
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

8.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 9.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

10.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.